Radiopharm Theranostics Health Care

$0.105 -0.010 (-8.70%)

High $0.12	Low $0.10	Trades 57	Turnover $206,557	Volume 1,951,148
30 June 2023 at 4:10pm

Register to track RAD and receive email alerts.

Market Cap (19-Sep) $44,934,040 (0th)	Close (30-Jun) $0.105 0 (0%)	Volume (30-Jun) 1,951,148	Shortsold (26-May) 2,077,074 (0.06%) (491st)
52w High $0.040	52w Low $0.017	P/E -	EPS -0.02

	Subject
	RAD RAD Ann: Notification of Release of Shares from Escrow
	1 (current) 2 3
	RAD RAD Ann: Update - Proposed issue of securities
	RAD RAD Ann: Entitlement Offer - Extension of Retail Offer
	RAD RAD Ann: Change in substantial holding - PH
	RAD RAD Ann: Change of Director's Interest Notice - PH
	RAD RAD Ann: Change of Director's Interest Notice - RC
	RAD RAD Ann: Notice Under Section 708A
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RAD RAD Ann: RAD agreement with NorthStar for supply of Actinium-225
	RAD RAD Ann: Entitlement Offer - Letter to Ineligible Shareholders
	RAD RAD Ann: Entitlement Offer - Letter to Option Holders
	RAD RAD Ann: Entitlement Offer - Letter to Eligible Retail Shareholders
	RAD RAD Ann: Appendix 2A
	RAD RAD Ann: Update - Proposed issue of securities
	RAD RAD Ann: Reinstatement to Quotation
	RAD RAD Ann: Supplementary Prospectus
	RAD RAD Ann: Successful Completion of Institutional Entitlement Offer
	RAD RAD Ann: Update - Proposed issue of securities - RAD
	RAD RAD Ann: Entitlement Offer - Presentation
	RAD RAD Ann: Entitlement Offer to raise up to $10 million
	RAD RAD Ann: Prospectus
	RAD RAD Ann: Proposed issue of securities - RAD
	RAD RAD Ann: Investor webinar - Pivalate positive Phase 2 data
	RAD RAD Ann: Presentation - Pivalate achieves positive Phase 2 data
	RAD RAD Ann: Pivalate achieves positive Phase 2 data in brain mets trial
	RAD RAD Article: Radiopharm in $10m rights issue
	RAD RAD Ann: Suspension from Official Quotation
	RAD RAD Ann: Notice of Annual General Meeting/Proxy Form
	RAD RAD Ann: Trading Halt
	RAD RAD Ann: Additional Information - LR4.10.19
	RAD RAD Ann: NATURE releases encouraging data on role of DUNP19 receptors
	RAD RAD Ann: Corporate Governance Statement
	RAD RAD Ann: ESG Report
	RAD RAD Ann: Appendix 4G
	RAD RAD Ann: Corporate Governance Statement
	RAD RAD Ann: Annual Report to shareholders
	RAD RAD Ann: Ga68-Integrin (RAD301) selected for presentation at EANM
	RAD RAD Ann: Pivalate phase II data to be presented at October conference
	RAD RAD Ann: Notification regarding unquoted securities - RAD
	RAD RAD Ann: RAD and SHINE Supply Agreement for Cancer-Fighting Isotope
	RAD RAD Ann: FDA grants pediatric disease designation for DUNP19-revised
	RAD RAD Ann: FDA grants rare pediatric disease designation for DUNP19
	RAD RAD Ann: JV with MD Anderson to develop novel radiopharmaceuticals
	RAD RAD Ann: FDA grants Orphan drug status to RAD DUNP19 for Osteosarcoma
	RAD RAD Ann: Appendix 4E and Preliminary Final Report - unaudited
	RAD RAD Ann: Application for quotation of securities - RAD
	RAD RAD Ann: Appendix 4E and Preliminary Final Report
	RAD RAD Ann: Notification of Release of Shares from Escrow
	RAD RAD Ann: Strategic agreements with Lantheus and NanoMab

Register to track RAD and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	7,214,173	+0.00 (9.68%)
12-Sep	$0.03	19,871,583	+0.00 (6.90%)
11-Sep	$0.03	6,388,015	+0.00 (3.57%)
05-Sep	$0.03	2,120,535	0.00 (0.00%)
04-Sep	$0.03	4,651,023	+0.00 (5.66%)
03-Sep	$0.03	599,603	0.00 (5.36%)
29-Aug	$0.03	977,963	+0.00 (1.82%)
28-Aug	$0.03	1,712,009	+0.00 (1.85%)
22-Aug	$0.03	3,476,593	0.00 (10.00%)
21-Aug	$0.03	46,600,598	+0.00 (15.38%)
15-Aug	$0.03	2,085,119	+0.00 (6.12%)
14-Aug	$0.02	1,820,018	+0.00 (2.08%)
07-Aug	$0.02	1,331,698	+0.00 (4.35%)
31-Jul	$0.02	1,851,822	+0.00 (4.55%)
30-Jul	$0.02	3,321,092	0.00 (0.00%)
11 up, 2 down, and 2 flat days